Cathie Wood's position in 10x Genomics is currently worth $102 Million. That's 0.75% of their equity portfolio (30th largest holding). The investor owns 3.59% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares five more times and sold shares on three occasions. The investor's estimated purchase price is $540 Million, resulting in a loss of 81%.